Difference between revisions of "Wang Y, et al. Int. J. Mol. Med. (2014) cited as Ref 387 in DOI: 10.1038/s41392-020-0110-5 (Q9650)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 34, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): The combinatory effects of PPAR-gamma agonist and survivin inhibition on the cancer stem-like phenotype and cell proliferation in bladder cancer cells, #quickstatements; #temporary_batch_1590010982689) |
||
| Property / title | |||
| + | The combinatory effects of PPAR-gamma agonist and survivin inhibition on the cancer stem-like phenotype and cell proliferation in bladder cancer cells (English) | ||
| Property / title: The combinatory effects of PPAR-gamma agonist and survivin inhibition on the cancer stem-like phenotype and cell proliferation in bladder cancer cells (English) / rank | |||
| + | Normal rank | ||
Revision as of 22:00, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Wang Y, et al. Int. J. Mol. Med. (2014) cited as Ref 387 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Wang Y
0 references
2014
0 references
Int. J. Mol. Med.
0 references
34
0 references
The combinatory effects of PPAR-gamma agonist and survivin inhibition on the cancer stem-like phenotype and cell proliferation in bladder cancer cells (English)
0 references
